Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
暂无分享,去创建一个
P. Ghezzi | S. Canevari | S. Sacco | M. Gadina | D. Mezzanzanica | F. Benigni | G. Finocchiaro | L. Cajola | D. Negri | Massimo Gadina | Pietro Ghezzi | Fabio Benigni | Silvano Sacco | Donatella R.M. Negri | Laura Cajola | Gaetano Finocchiaro | Silvana Canevari
[1] A. Körner,et al. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. , 2000, Cancer research.
[2] A. Inui,et al. Cancer anorexia-cachexia syndrome: are neuropeptides the key? , 1999, Cancer research.
[3] C. Plata-salamán,et al. Brain tumor development in rats is associated with changes in central nervous system cytokine and neuropeptide systems , 1999, Brain Research Bulletin.
[4] Shengfang Jin,et al. Regulation of DNA-dependent Protein Kinase by the Lyn Tyrosine Kinase* , 1998, The Journal of Biological Chemistry.
[5] C. Plata-salamán,et al. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. , 1998, The American journal of physiology.
[6] A. Miyajima,et al. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] C. Plata-salamán,et al. Cytokines and anorexia: a brief overview. , 1998, Seminars in oncology.
[8] M. Tisdale. Biology of cachexia. , 1997, Journal of the National Cancer Institute.
[9] A. Billiau,et al. Cytokines and cachexia. , 1997, Nutrition.
[10] F. López‐Soriano,et al. Journey from cachexia to obesity by TNF , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] H. Ishitsuka,et al. Murine interleukin‐12 prevents the development of cancer cachexia in a murine model , 1996, International journal of cancer.
[12] C. Plata-salamán,et al. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations , 1996, Physiology & Behavior.
[13] W. Fiers,et al. Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor‐induced cachexia , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] C. Plata-salamán. Anorexia induced by activators of the signal transducer gp 130 , 1996, Neuroreport.
[15] C. Plata-salamán. Anorexia during acute and chronic disease. , 1996, Nutrition.
[16] H. Ishitsuka,et al. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] H. Ishitsuka,et al. Establishment and characterization of cachexia‐inducing and ‐non‐inducing clones of murine colon 26 carcinoma , 1995, International journal of cancer.
[18] J. Blay,et al. Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. , 1994, Blood.
[19] W. Banks,et al. Blood‐borne interleukin‐1 alpha is transported across the endothelial blood‐spinal cord barrier of mice. , 1994, The Journal of physiology.
[20] G. Strassmann,et al. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. , 1993, Journal of immunology.
[21] G. Strassmann,et al. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. , 1992, The Journal of clinical investigation.
[22] P. Ghezzi,et al. Evidence for a different sensitivity to various central effects of interleukin-1 β in mice , 1992, Brain Research Bulletin.
[23] K. Abe,et al. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. , 1991, Cancer research.
[24] A. Billiau,et al. Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells , 1991 .
[25] G. Mundy,et al. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. , 1991, Endocrinology.
[26] H. Langstein,et al. The Roles of γ-Interferon and Tumor Necrosis Factor α in an Experimental Rat Model of Cancer Cachexia , 1991 .
[27] T. Fahey,et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. , 1990, The Journal of clinical investigation.
[28] A. Mantovani,et al. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6 , 1990, The Journal of experimental medicine.
[29] W. Banks,et al. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier , 1989, Brain Research Bulletin.
[30] D. Gearing,et al. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] K. Tracey,et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.
[32] A. Mantovani,et al. IL-1 stimulates IL-6 production in endothelial cells. , 1989, Journal of immunology.
[33] D. Hilton,et al. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. Moldawer,et al. Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. , 1987, Clinical physiology.
[35] R. A. Brennan,et al. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals. , 1987, Journal of the National Cancer Institute.
[36] T. Taniguchi,et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.
[37] M. Yamada,et al. Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. , 1985, Nucleic acids research.
[38] B. Beutler,et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin , 1985, Nature.
[39] D. Goeddel,et al. Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.
[40] A. C. Webb,et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[41] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.
[42] W. Degrave,et al. Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. , 1982, Nucleic acids research.
[43] K. Nelson,et al. The cancer anorexia-cachexia syndrome. , 2000, Seminars in oncology.
[44] T. Okusaka,et al. Elevated serum interleukin-6 levels in patients with pancreatic cancer. , 1998, Japanese journal of clinical oncology.
[45] M. Yano,et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. , 1996, The Journal of clinical investigation.
[46] P. Ghezzi,et al. Proinflammatory cytokines as pathogenetic mediators in the central nervous system: brain-periphery connections. , 1995, Neuroimmunomodulation.
[47] C. Franzblau,et al. Rapid, sensitive enzyme-linked immunosorbent assays (ELISA) foi serum amyloid A (apoSAA) in human plasma and tissue culture fluids1 , 1994 .
[48] G. Opdenakker,et al. Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. , 1991, European journal of cancer.
[49] P. Coulie,et al. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo. , 1990, Current topics in microbiology and immunology.
[50] P. Ghezzi,et al. Effects of cancer disease on the metabolism of anticancer agents. , 1988, Pharmacology & therapeutics.